280 related articles for article (PubMed ID: 140441)
1. [Immunological aspects of malignant lymphoproliferative diseases].
Rivero I; Diumenjo M
Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
[No Abstract] [Full Text] [Related]
2. Malignant disease of the lymphoid system in immunological perspective.
Hansen JA; Good RA
Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
[No Abstract] [Full Text] [Related]
3. [Immunological behavior of patients with malignant blood diseases].
Luca N
Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
[No Abstract] [Full Text] [Related]
4. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
5. [T-and B-lymphocytes in lymphoproliferative syndromes].
Girard JP; Fernandes B
Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
[TBL] [Abstract][Full Text] [Related]
6. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
Mantovani G; Petrini MT; Tognella S; Grifoni V
Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
[No Abstract] [Full Text] [Related]
7. [Immunology of lymphocytes in leukemia].
Astaldi G; Astaldi GC
Recenti Prog Med; 1975 Sep; 59(3):248-65. PubMed ID: 131361
[No Abstract] [Full Text] [Related]
8. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
Tanaka E
Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
[No Abstract] [Full Text] [Related]
9. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
Ponzone A; Tarocco RP; Nicola P
Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
[No Abstract] [Full Text] [Related]
10. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H
Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte surface markers in lymphoproliferative disorders.
Aiuti F; Lacava V; Fiorilli M; Ciarla MV
Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
[No Abstract] [Full Text] [Related]
12. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
Brouet JC; Flandrin G
Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Sézary syndrome.
Br Med J; 1975 Mar; 1(5958):590-1. PubMed ID: 123808
[No Abstract] [Full Text] [Related]
14. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
Seligmann M; Preud'Homme JL; Brouet JC
Transplant Rev; 1973; 16():85-113. PubMed ID: 4204588
[No Abstract] [Full Text] [Related]
15. [Membrane markers in chronic lymphoproliferative diseases].
Matutes E; San Miguel JF; Catovsky D
Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
[No Abstract] [Full Text] [Related]
16. [Immunological deficiency in various disorders of lymphoreticular system].
Frydecka I
Pol Tyg Lek; 1977 May; 32(22):851-3. PubMed ID: 407553
[No Abstract] [Full Text] [Related]
17. Immune deficiency states associated with malignant disease in man.
Harris J; Bagai RC
Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
[No Abstract] [Full Text] [Related]
18. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
Do TP; Petrányi G; Hollán Z
Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
[No Abstract] [Full Text] [Related]
19. Cellular structure and function in normal and neoplastic lymphoid cells.
Zucker-Franklin D
Arch Intern Med; 1975 Jan; 135(1):55-60. PubMed ID: 163073
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of B cell neoplasia.
Deegan MJ
Henry Ford Hosp Med J; 1984; 32(1):20-30. PubMed ID: 6204956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
